| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/25/2008 | CN100396330C Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 06/25/2008 | CN100396322C Capsule for treating proliferation of mammary gland and its production method |
| 06/25/2008 | CN100396297C Composition of Chinese traditional medicine for treating cardiovascular diseases |
| 06/25/2008 | CN100396293C Wetting burn ointment |
| 06/25/2008 | CN100396292C Traditional Chinese medicine powder for treating cervical erosio |
| 06/25/2008 | CN100396289C Scutellarin injection preparation and its preparing method |
| 06/25/2008 | CN100396288C Use of pennogenin in preparing medicines for enhance of hemopoietic function |
| 06/25/2008 | CN100396287C Formulation containing phosphate derivatives of electron transfer agents |
| 06/25/2008 | CN100396286C Use of homoharringtonine and harringtonine in inhibiting vascularization |
| 06/25/2008 | CN100396285C Inhalative solution formulation containing tiotropium salt |
| 06/25/2008 | CN100396284C Novel galneical form for oral administration with prolonged release of molsidomine |
| 06/25/2008 | CN100396283C Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| 06/25/2008 | CN100396282C Slow released doxazosin mesilate capsule and its preparation process |
| 06/25/2008 | CN100396281C Use of rotigotine for treating the restless leg syndrome |
| 06/25/2008 | CN100396280C Application of asafetida and volatile asafetida oil in preparing anticancer medicine |
| 06/25/2008 | CN100396277C Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 06/25/2008 | CN100396276C Compositions containing organic compounds |
| 06/24/2008 | US7390925 Alzheimer's disease; compounds inhibit the production of A beta -peptide; improved pharmacokinetics; N-((4-amino-3,5-dichlorobenzylamino)(amino)methylene)-3-(isobutoxyimino)-3-(4-methoxyphenyl)propanamide |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390923 novel non-steroidal propionanilide structured compounds; useful in hormonal therapy, male hypogonadism, andropause; 3-(4-Acetylamino-3-fluorophenoxy)-2-hydroxy-2-methyl-N-(3-methyl-4-nitrophenyl)propionamide; good water solubility; beneficial androgenic effects without harmful stimulation of prostate |
| 06/24/2008 | US7390922 Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use |
| 06/24/2008 | US7390915 Phosphine transition metal complex having ferrocene skeleton, process for making the same, and anti-cancer agent |
| 06/24/2008 | US7390910 Antitumor, anticancer agents; for drug resistant tumors, cancers |
| 06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 06/24/2008 | US7390907 Vanilloid receptor ligands and their use in treatments |
| 06/24/2008 | US7390906 Forming ketone intermediates to terfenadine carboxylic acid metabolite; by use of pure regioisomer of 4-(Cyclopropyl-oxo-methyl)-alpha,alpha-dimethylphenylacetic acid |
| 06/24/2008 | US7390905 Tachykinin receptor antagonists for use treating e.g. emesis, depression, urinary disorder |
| 06/24/2008 | US7390902 N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-2-methoxy-5-iodo-benzamide; high affinity and high selectivity for sigma 2 receptors; Bromine, Iodine, Carbon, Tritium radioisitops; PET and SPECT; breast cancer |
| 06/24/2008 | US7390898 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 06/24/2008 | US7390896 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 06/24/2008 | US7390895 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 06/24/2008 | US7390890 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 06/24/2008 | US7390884 Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease |
| 06/24/2008 | US7390873 Microbiocides; bactericides |
| 06/24/2008 | US7390838 Depigmenting agents |
| 06/24/2008 | US7390837 Germicidal compositions containing phenylmalonaldehyde-type compounds, or mixtures of phenylmalonaldehyde-type compounds and phthalaldehydes, and methods of using such compositions for disinfection or sterilization |
| 06/24/2008 | US7390836 For disrupting interactions between polypeptides, such as inhibition of heterodimerization between apoptotic and antiapoptotic members of the bcl-2 protein family; anticancer agents |
| 06/24/2008 | US7390834 Increased or improved bioavailability of the active agents for oral, intracolonic, pulmonary, and other routes of administrations |
| 06/24/2008 | US7390833 osteoarthritis; compounds inhibit Aggrecanase Activity of a disintegrin and metalloprotease with thrombosondin type I motifs; biaryl sulfonamid derivatives; N-({4'-[2-4-methylisoquinolin-3-yl)ethyl]-1,1 '-biphenyl-4-yl}sulfonyl)-D-valine |
| 06/24/2008 | US7390832 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment |
| 06/24/2008 | US7390831 contraception, secondary amenorrhea; dysfunctional bleeding; uterine leiomyomata; endometriosis; polycystic ovary syndrome; carcinomas, adenocarcinomas, Syndrome X, diabetes; 3'H-spiro-[[1,3]-dioxol-11,12-Dihydroxy-13-methyl-1,6,7,8,11,12,13,14,15,16-decahydro-2H-cyclopenta[a]phenanthrene-3,17-dione |
| 06/24/2008 | US7390830 MIP-1 alpha and/or MCP-1 antagonists; rheumatoid arthritis; nephritis; multiple sclerosis; nephropathy |
| 06/24/2008 | US7390829 4-(3-Hydroxymethyl-cyclohex-3-enylmethyl)-1,3-dihydro-imidzole-2-thione; side effects reduction; analgesics; chronic neuropathic and visceral pain; for reducing intraocular pressure |
| 06/24/2008 | US7390828 Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents |
| 06/24/2008 | US7390827 Herbicides for selectively controlling broadleaf and gramineous weeds in crops of useful plants, especially in rice crops |
| 06/24/2008 | US7390826 Inhibitors of animal cell motility and growth |
| 06/24/2008 | US7390825 Process for the preparation of oxazolidinones and method of use thereof |
| 06/24/2008 | US7390824 Via oxazole derivatives, biphenyl-2-oxazole-alkanoic acid derivatives, 2-thio-4,5-diphenyloxazole S-derivatives; fatty acid binding proteins (aP2) |
| 06/24/2008 | US7390823 Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders |
| 06/24/2008 | US7390822 Delta-2 opioid receptor agonists; protecting cardiac and cerebral organs |
| 06/24/2008 | US7390821 Administering nicotinic acetylcholine receptor antagonist; ocular diseases; monoclonal antibodies |
| 06/24/2008 | US7390820 Substituted quinolinone derivatives and methods of use |
| 06/24/2008 | US7390819 Imidazo[4,5-b]quinoline-derivatives and their use as no-synthase inhibitors |
| 06/24/2008 | US7390818 3-(2,4-dimethoxyphenyl)-1,9-dimethyl-2-oxo-2,9-dihydro-1H-pyrido[2,3-b]indole-6-carboxylic acid; gamma-aminobutyric acid modulator; anticarcinogenic, antitumor, antiproliferative agent |
| 06/24/2008 | US7390817 Combinations of a vanilloid antagonist and an NSAID for the treatment of pain |
| 06/24/2008 | US7390816 Methods for treating urinary incontinence in patients suffering from memory disorders |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390813 Metabolic syndrome and lipid metabolism, especially diseases of fatty acid and cholesterol metabolism, such as those mediated by stearoyl-CoA desaturase |
| 06/24/2008 | US7390812 N, N'-disubstituted piperazine compounds and their use as analgesics |
| 06/24/2008 | US7390811 Respiratory syncytial virus replication inhibitors |
| 06/24/2008 | US7390810 Pyrazole-amine compounds useful as kinase inhibitors |
| 06/24/2008 | US7390809 7-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-2-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5- alpha ]pyrazine, hydrochloride; antidiabetic agent, non-insulin dependent diabetes; synergistic mixture with other active ingredients |
| 06/24/2008 | US7390808 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes |
| 06/24/2008 | US7390807 Crystal forms of lamotrigine and processes for their preparations |
| 06/24/2008 | US7390806 Antibiotics containing borinic acid complexes and methods of use |
| 06/24/2008 | US7390805 Tyrosine kinase inhibitors; antiproliferative agents; antitumor agents |
| 06/24/2008 | US7390804 formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition |
| 06/24/2008 | US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma |
| 06/24/2008 | US7390802 Substituted lactams as inhibitors of Aβ protein production |
| 06/24/2008 | US7390801 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/24/2008 | US7390800 from a soil; 1,3-diazepine-4-one; antibacterial and anticarcinogenic agent; use for ATP synthesis; low toxicity; micromolecule compound |
| 06/24/2008 | US7390799 N-acylsulfonamides; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohex-1-en-1-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(morpholin-4-yl)-1-((phenylsulfanyl)methyl)propyl)amino)-3-((trifluoromethyl)sulfonyl)benzenesulfonamide |
| 06/24/2008 | US7390798 Carboxamide spirolactam CGRP receptor antagonists |
| 06/24/2008 | US7390797 Fused indazole compounds |
| 06/24/2008 | US7390796 Fatty acid modified forms of glucocorticoids |
| 06/24/2008 | US7390795 Treatment and prevention of tissue damage |
| 06/24/2008 | US7390793 Have fixed, preselected hydrodynamic diameters and are formed from basic or acidic amphiphilic compounds; compound E5564 and derivatives |
| 06/24/2008 | US7390792 Method of reducing Delta protein expression in a cell comprising the steps of introducing into the cell miR-1 and detecting a resultant reduction of Delta protein expression in the cell; resultant reduction is quantitatively detected |
| 06/24/2008 | US7390791 Prodrugs of phosphonate nucleotide analogues |
| 06/24/2008 | US7390790 Antilipemic agents; anticholesterol agents, for example, 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylcarbamoyl}phenoxy)benzoic acid |
| 06/24/2008 | US7390783 Charged phospholipid compositions and methods for their use |
| 06/24/2008 | US7390782 Methods and products related to metabolic interactions in disease |
| 06/24/2008 | US7390781 Methods of using truncated glial cell line-derived neurotrophic factor |
| 06/24/2008 | US7390780 For transfecting nucleic acids in vivo or ex vivo; vesicle forming lipid and hydrophilic polymer; gene therapy |
| 06/24/2008 | US7390668 Halogenated xanthan compound |
| 06/24/2008 | US7390633 Methods for preparing low molecular weight heparin with modified heparinase III |
| 06/24/2008 | US7390629 Tumor-activated prodrug compounds and treatment |
| 06/24/2008 | US7390516 Caralluma extract products and processes for making the same |
| 06/24/2008 | US7390513 Theobromine, L-phenylalanine, nicotinamide adenine dinucleotide, cayenne pepper, and green tea; human dietary supplement to increase energy; nutraceuticals |
| 06/24/2008 | US7390511 Compositions containing vitamin E and saw palmetto |
| 06/24/2008 | US7390509 Compositions and methods for nutrition supplementation |
| 06/24/2008 | US7390507 Distilled omega-3 fish oils (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), gamma-linoleic acid, tocopherols, lavender oil, and carrier; sodium-2-pyrrolidone-5-carboxylate or dimethyl sulfone; wrinkle and aging resistance; sunscreen agents; dermatology |
| 06/24/2008 | US7390506 Substituted or unsubstituted 5-nitrothiazole covalently attached to a lipid selected from fatty acids or esters; oral administration; parasitic, bacterial, viral, or fungal infections; equine protozoal myeloencephalitis (EPM) or coccidiosis; drug delivery, nontoxic, bioavailability |
| 06/24/2008 | US7390505 Nanoparticulate topiramate formulations |
| 06/24/2008 | US7390504 HDL-boosting combination therapy complexes |
| 06/24/2008 | US7390502 Administering a mammalian host for treating a disease caused by proliferation of eukaryotic cells a formulation containing a complex of lipid and a drug 7-ethyl-10-hydroxycamptothecin |
| 06/24/2008 | US7390500 Transdermal therapeutic system (TTS) with fentanyl as a active ingredient |
| 06/24/2008 | US7390499 Wound healing agents; mixture of cellulose and microbiocide |
| 06/24/2008 | US7390497 Poly(ester amide) filler blends for modulation of coating properties |
| 06/24/2008 | US7390488 Administering platelet binding agent; complexing; activation of complex; thrombosis |